1. Home
  2. STRO vs RNGR Comparison

STRO vs RNGR Comparison

Compare STRO & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • RNGR
  • Stock Information
  • Founded
  • STRO 2003
  • RNGR 2017
  • Country
  • STRO United States
  • RNGR United States
  • Employees
  • STRO N/A
  • RNGR N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • RNGR Oilfield Services/Equipment
  • Sector
  • STRO Health Care
  • RNGR Energy
  • Exchange
  • STRO Nasdaq
  • RNGR Nasdaq
  • Market Cap
  • STRO 77.7M
  • RNGR 279.8M
  • IPO Year
  • STRO 2018
  • RNGR 2017
  • Fundamental
  • Price
  • STRO $0.75
  • RNGR $12.01
  • Analyst Decision
  • STRO Hold
  • RNGR Hold
  • Analyst Count
  • STRO 7
  • RNGR 2
  • Target Price
  • STRO $3.97
  • RNGR $12.50
  • AVG Volume (30 Days)
  • STRO 1.4M
  • RNGR 289.3K
  • Earning Date
  • STRO 08-12-2025
  • RNGR 07-28-2025
  • Dividend Yield
  • STRO N/A
  • RNGR 2.01%
  • EPS Growth
  • STRO N/A
  • RNGR 27.70
  • EPS
  • STRO N/A
  • RNGR 0.87
  • Revenue
  • STRO $66,434,000.00
  • RNGR $569,400,000.00
  • Revenue This Year
  • STRO N/A
  • RNGR $11.70
  • Revenue Next Year
  • STRO N/A
  • RNGR N/A
  • P/E Ratio
  • STRO N/A
  • RNGR $14.02
  • Revenue Growth
  • STRO N/A
  • RNGR N/A
  • 52 Week Low
  • STRO $0.52
  • RNGR $9.92
  • 52 Week High
  • STRO $5.17
  • RNGR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • STRO 38.33
  • RNGR 50.99
  • Support Level
  • STRO $0.76
  • RNGR $11.93
  • Resistance Level
  • STRO $0.87
  • RNGR $13.16
  • Average True Range (ATR)
  • STRO 0.07
  • RNGR 0.41
  • MACD
  • STRO -0.01
  • RNGR -0.03
  • Stochastic Oscillator
  • STRO 0.00
  • RNGR 21.95

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.

Share on Social Networks: